Search Results

PharmaLogic Holdings Corp., a world-class contract development and manufacturing organization and radiopharmacy solutions provider, celebrates the opening of its radiopharmaceutical production and research facility in the Bronx, New York.

PharmaLogic Holdings Corp. announced the opening of its new radiopharmaceutical production and research facility in Cincinnati, Ohio.

Ratio Therapeutics Inc. announced an expanded manufacturing agreement with PharmaLogic, a world-class contract development and manufacturing organization specializing in radiopharmaceutical production and distribution.

Eckert & Ziegler and PharmaLogic Holdings Corp. have signed a reservation agreement for the supply of the therapeutic radioisotope Actinium-225.

Meilleur Technologies Inc. announced it has signed an agreement with PharmaLogic Holdings Corporation granting PharmaLogic the rights to manufacture fluorine-18 [F18]NAV4694, a next-generation investigational imaging biomarker used in Positron Emission Tomography imaging studies to assess the status of amyloid plaque in the brain.